Wellness Index Report, an independent wellness ratings and education platform, has recognized Nefense as a leader in nasal health innovation in a new "Inside the Index" feature. The article examines Nefense's portfolio of hypochlorous acid (HOCl) and xylitol-based products, which are gaining attention as drug-free alternatives to traditional nasal care solutions.
Founder Lindsay O'Neill-O'Keefe emphasized the growing importance of nasal wellness, noting that consumers are seeking science-backed approaches beyond conventional saline sprays. Nefense's products, including HypoNasal HOCl Nasal Spray, HypoNasal Junior for kids, HypoBaby for infants, and XyloClean xylitol solutions, are designed for daily hygiene and respiratory wellness.
The feature draws on articles in TopDoctor Magazine and Business Insider, exploring the science behind hypochlorous acid, a molecule produced by white blood cells with antimicrobial and anti-inflammatory properties. Research has shown potential applications in respiratory health, wound care, and infection control, driving interest in natural alternatives for allergy relief and nasal congestion.
According to Wellness Index Report, Nefense represents a new generation of companies prioritizing daily wellness routines over symptom management. The products are doctor-recommended, ENT-approved, and formulated under Dr. Richard Downs DDS. For more on the science behind Nefense, visit https://nefense.com/science.
The full article, "Why Nefense Is Reimagining Nasal Wellness for Modern Families," is available through the Inside the Index news section of Wellness Index Report.
